The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study | |
Zhang JianZhong; Tsai Tsen-Fang; Lee Min-Geol; Zheng Min; Wang Gang; Jin HongZhong; Gu Jun; Li RuoYu; Liu QuanZhong; Chen Jin | |
2017 | |
卷号 | 88期号:1页码:36-45 |
关键词 | Asia Efficacy Janus kinase inhibitor Plaque psoriasis Safety Tofacitinib |
ISSN号 | 1873-569X |
DOI | 10.1016/j.jdermsci.2017.05.004 |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6368240 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang JianZhong,Tsai Tsen-Fang,Lee Min-Geol,et al. The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study[J],2017,88(1):36-45. |
APA | Zhang JianZhong.,Tsai Tsen-Fang.,Lee Min-Geol.,Zheng Min.,Wang Gang.,...&Crook Tim.(2017).The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study.,88(1),36-45. |
MLA | Zhang JianZhong,et al."The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study".88.1(2017):36-45. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论